Showing 2 posts of 2 posts found.
Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials